
Menstrual tracking app data in the wrong hands ‘could result in risks to job prospects, workplace monitoring'
Experts say companies could sell the data of those who use menstrual cycle tracking apps. (Pexels)
Menstrual cycle tracking apps could jeopardize the safety and privacy of users, a new report warns, with personal data commonly sold to companies.
The stakes are high since period tracking apps have soared in popularity and become ubiquitous amid limited access to information, a lack of research and stigma about menstruation health.
A 2024 study estimates that global downloads for the three most popular menstruation cycle tracking apps surpassed 250 million.
Those who use apps that track periods often don't consider the data 'intimate' or commercially valuable, and need more protections from potential abuse of their personal information, according to the report released Tuesday, by The Minderoo Centre for Technology and Democracy (MCTD), an independent team of academic researchers at the University of Cambridge in the U.K. would split up this long list of proper names
'Menstrual tracking applications turn personal health information into data points to be collected, analyzed, and sold,' according to the report.
Data sold to companies, advertisers
The study noted the apps pose 'significant risks' for users as femtech has become a 'lucrative trend' and the user data is 'extremely valuable' for a wide range of companies, from those that developed the app to big tech firms and advertising industries.
Femtech refers to digital products, services or technologies promoting women's health and wellbeing, with period-tracking apps making up 50 per cent of the US$22 billion market in 2020.
'People vastly underestimate the commercial value of menstrual data and the extent to which it can provide insights into their political preferences, health issues, or reproductive choices,' researchers wrote.
The apps offer a way for users to track daily information on anything related to their menstrual health, such as menstrual cycles, predictions on periods, premenstrual syndrome (PMS), ovulation and fertility.
Security and privacy risks
To add to the concerns, researchers say the apps also pose risks to data security and privacy, noting it's widely used in the online advertising industry.
'Self-tracking data has been used to police people's reproductive choices, to undermine a user's testimony in court, and it can lead to increased vulnerability in intimate relationships, partner violence, risks to job prospects via employer access to CTA (cycle tracking application) data, workplace monitoring, or possible health insurance discrimination,' according to the report.
Meanwhile, the report also referred to 'severe security risks,' noting an example in the U.K. where period tracker data was used to charge women for illegally accessing abortion services.
Are period apps accurate?
The study notes many medical studies showed that the apps 'fail to accurately calculate cycle length or ovulation windows' and additional data from people is often not used to improve predictions. Rather, researchers say the information is 'predominantly a source of value' for the companies.
'With most apps providing no or very little information on how predictions are made, a 2023 study found that some users were encouraged to track more data to fine-tune their predictions and train an imagined algorithm,' it wrote.
While users commonly turn to the apps for help them conceive or prevent getting pregnant, people with irregular cycles or conditions such as poly-cystic ovary syndrome, endometriosis, or premenstrual dysphoric disorder may also use the apps to try to understand their medical issues. Many people use the apps to track their emotions and bodily functions as well.
Recommendations
The report recommends improving health care for and incentivising research on menstrual and reproductive health, such as through cycle tracking companies and research institutes working together. It encourages schools and organizations to help raise awareness about menstrual tracking for all ages.
Additionally, it recommends alternatives, such as public bodies developing apps that are 'trustworthy' and collect data in a 'responsible way.'
The report also calls for stricter regulation of menstrual tracking data as 'sensitive health information' in the United States and tighter enforcement of existing regulations in the U.K. and European Union. It suggests improving security through 'consent options,' clear and accessible privacy policies, and prioritizing data privacy and security in the app design. Apps could be more 'transparent' by providing clear information on how tracking data is used to make predictions, with interface options for those who cannot or do not want to become pregnant.
The report notes that not all women menstruate and not everyone with menstrual cycles is a woman. For instance, it wrote that children and teenagers have periods, trans men can menstruate and trans women can experience symptoms similar to premenstrual syndrome (PMS). Most apps are designed for straight cis women who want to get pregnant, it added.
David Young, a privacy and regulatory law expert in Toronto, told CTVNews.ca in a video interview Monday that Canada's Personal Information Protection and Electronic Documents Act already follows the report's recommendations, though the law is 'not always enforced.'
According to Canada's federal privacy law, an organization must not require individuals to consent to the collection, use or disclosure of their information beyond 'explicitly specified, and legitimate purposes.'
'Assuming those specific and legitimate purposes are the tracking that the individual is seeking by use of the app, then they shouldn't be allowed to also require, as a condition of using the app, that they're going to sell that information to somebody else,' Young said. He noted Canada also faces a problem with companies selling consumers' medical data, including electronic health records.
Young said menstrual-related cycle data is considered 'sensitive personal health information.'
'And that has a very high standard of compliance under any privacy law, meaning that there must be clear ... consent to for whatever uses are going to be made of that information. So it's not something you can just use by way of implied consent.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

National Post
an hour ago
- National Post
Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies
Article content CAMBRIDGE, England & SEATTLE — The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Article content Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Article content Article content Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Article content Garnett's research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capture hallmarks of patient tumors. The team will use vast numbers of these tumor organoids — mini tumors in a dish — as a model to better understand cancer mechanisms of plasticity and adaptability in response to treatments. Article content Theis' research team has been widely recognized for pioneering computational algorithms to solve complex biological challenges at the intersection of Artificial Intelligence and single cell genomics, in this context for in silico modeling of drug effects on cellular systems. The initiative will be run through Parse Biosciences' GigaLab, a state-of-the-art facility purpose built for the generation of massive scale single cell RNA sequencing datasets at unprecedented speed. Article content The Sanger, Helmholtz Munich, and Parse teams have developed automated methods to streamline laboratory procedures in addition to the computational methods required to analyze and discover insights within datasets of this size. Article content The ultimate aim of the collaboration is to build a single cell reference map that will enable virtual cell modeling and potentially help predict the effect of drugs in cancer patients – where resistance might develop, from which compounds, and where to target future treatment efforts. Article content Garnett, Group Leader at the Wellcome Sanger Institute and collaboration co-lead, said: 'We have developed a transformational platform to enable both large-scale organoid screening and the downstream data generation and analysis which has the potential to redefine our understanding of therapeutic responses in cancer. We aim to develop a community that brings the best expertise from academia and industry to progress the project. Studies of this magnitude are critical to the development of foundational models to better help us understand cancer progression and bring much needed advancement in the field.' Article content Theis, Director of the Computational Health Center at Helmholtz Munich and collaboration co-lead, said: 'Our vision of a virtual cell perturbation model is becoming increasingly feasible with recent advances in AI — but to scale effectively, we need large, high-quality single cell perturbation datasets. This collaboration enables that scale, and I'm excited to move toward AI-driven experimental design in drug discovery.' Article content Dr. Charlie Roco, Chief Technology Officer at Parse Biosciences, said: 'We are incredibly excited to bring the power of GigaLab to visionary partners. Leveraging Parse's Evercode chemistry, the GigaLab can rapidly produce large single cell datasets with exceptional quality. Combining the expertise of the Wellcome Sanger Institute and Helmholtz Munich with the speed and scale achieved by the GigaLab enable the opportunity to fundamentally change our understanding of cancer.' Article content About Parse Biosciences Article content Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, its pioneering approach has enabled groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system. Article content With technology developed at the University of Washington by co-founders Alex Rosenberg and Charles Roco, Parse has raised over $100 million in capital and is used by over 2,500 customers across the world. Its growing portfolio of products includes Evercode™ Whole Transcriptome, Evercode™ TCR, Evercode™ BCR, Gene Select, and a solution for data analysis, Trailmaker™. Article content Parse Biosciences is based in Seattle's vibrant South Lake Union district, where it recently expanded into a new headquarters and state-of-the-art laboratory. To learn more, please visit Article content About Helmholtz Munich Article content Helmholtz Munich is a leading biomedical research center. Its mission is to develop breakthrough solutions for better health in a rapidly changing world. Interdisciplinary research teams focus on environmentally triggered diseases, especially the therapy and prevention of diabetes, obesity, allergies, and chronic lung diseases. With the power of artificial intelligence and bioengineering, researchers accelerate the translation to patients. Helmholtz Munich has around 2,500 employees and is headquartered in Munich/Neuherberg. It is a member of the Helmholtz Association, with more than 43,000 employees and 18 research centers the largest scientific organization in Germany. More about Helmholtz Munich (Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH): About the Wellcome Sanger Institute The Wellcome Sanger Institute is a world leading genomics research centre. We undertake large-scale research that forms the foundations of knowledge in biology and medicine. We are open and collaborative; our data, results, tools and technologies are shared across the globe to advance science. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth. Find out more at or follow us on Twitter, Facebook, LinkedIn and on our Blog. Article content Article content Article content


CTV News
2 hours ago
- CTV News
AI chatbots need more books to learn from
CAMBRIDGE, Mass — Everything ever said on the internet was just the start of teaching artificial intelligence about humanity. Tech companies are now tapping into an older repository of knowledge: the library stacks. Nearly one million books published as early as the 15th century — and in 254 languages — are part of a Harvard University collection being released to AI researchers Thursday. Also coming soon are troves of old newspapers and government documents held by Boston's public library. Cracking open the vaults to centuries-old tomes could be a data bonanza for tech companies battling lawsuits from living novelists, visual artists and others whose creative works have been scooped up without their consent to train AI chatbots. 'It is a prudent decision to start with public domain data because that's less controversial right now than content that's still under copyright,' said Burton Davis, a deputy general counsel at Microsoft. Davis said libraries also hold 'significant amounts of interesting cultural, historical and language data' that's missing from the past few decades of online commentary that AI chatbots have mostly learned from. Supported by 'unrestricted gifts' from Microsoft and ChatGPT maker OpenAI, the Harvard-based Institutional Data Initiative is working with libraries around the world on how to make their historic collections AI-ready in a way that also benefits libraries and the communities they serve. 'We're trying to move some of the power from this current AI moment back to these institutions,' said Aristana Scourtas, who manages research at Harvard Law School's Library Innovation Lab. 'Librarians have always been the stewards of data and the stewards of information.' Harvard's newly released dataset, Institutional Books 1.0, contains more than 394 million scanned pages of paper. One of the earlier works is from the 1400s — a Korean painter's handwritten thoughts about cultivating flowers and trees. The largest concentration of works is from the 19th century, on subjects such as literature, philosophy, law and agriculture, all of it meticulously preserved and organized by generations of librarians. It promises to be a boon for AI developers trying to improve the accuracy and reliability of their systems. 'A lot of the data that's been used in AI training has not come from original sources,' said the data initiative's executive director, Greg Leppert, who is also chief technologist at Harvard's Berkman Klein Center for Internet & Society. This book collection goes 'all the way back to the physical copy that was scanned by the institutions that actually collected those items,' he said. Before ChatGPT sparked a commercial AI frenzy, most AI researchers didn't think much about the provenance of the passages of text they pulled from Wikipedia, from social media forums like Reddit and sometimes from deep repositories of pirated books. They just needed lots of what computer scientists call tokens — units of data, each of which can represent a piece of a word. Harvard's new AI training collection has an estimated 242 billion tokens, an amount that's hard for humans to fathom but it's still just a drop of what's being fed into the most advanced AI systems. Facebook parent company Meta, for instance, has said the latest version of its AI large language model was trained on more than 30 trillion tokens pulled from text, images and videos. Meta is also battling a lawsuit from comedian Sarah Silverman and other published authors who accuse the company of stealing their books from 'shadow libraries' of pirated works. Now, with some reservations, the real libraries are standing up. OpenAI, which is also fighting a string of copyright lawsuits, donated US$50 million this year to a group of research institutions including Oxford University's 400-year-old Bodleian Library, which is digitizing rare texts and using AI to help transcribe them. When the company first reached out to the Boston Public Library, one of the biggest in the U.S., the library made clear that any information it digitized would be for everyone, said Jessica Chapel, its chief of digital and online services. 'OpenAI had this interest in massive amounts of training data. We have an interest in massive amounts of digital objects. So this is kind of just a case that things are aligning,' Chapel said. Digitization is expensive. It's been painstaking work, for instance, for Boston's library to scan and curate dozens of New England's French-language newspapers that were widely read in the late 19th and early 20th century by Canadian immigrant communities from Quebec. Now that such text is of use as training data, it helps bankroll projects that librarians want to do anyway. 'We've been very clear that, 'Hey, we're a public library,'' Chapel said. 'Our collections are held for public use, and anything we digitized as part of this project will be made public.' Harvard's collection was already digitized starting in 2006 for another tech giant, Google, in its controversial project to create a searchable online library of more than 20 million books. Google spent years beating back legal challenges from authors to its online book library, which included many newer and copyrighted works. It was finally settled in 2016 when the U.S. Supreme Court let stand lower court rulings that rejected copyright infringement claims. Now, for the first time, Google has worked with Harvard to retrieve public domain volumes from Google Books and clear the way for their release to AI developers. Copyright protections in the U.S. typically last for 95 years, and longer for sound recordings. How useful all of this will be for the next generation of AI tools remains to be seen as the data gets shared Thursday on the Hugging Face platform, which hosts datasets and open-source AI models that anyone can download. The book collection is more linguistically diverse than typical AI data sources. Fewer than half the volumes are in English, though European languages still dominate, particularly German, French, Italian, Spanish and Latin. A book collection steeped in 19th century thought could also be 'immensely critical' for the tech industry's efforts to build AI agents that can plan and reason as well as humans, Leppert said. 'At a university, you have a lot of pedagogy around what it means to reason,' Leppert said. 'You have a lot of scientific information about how to run processes and how to run analyses.' At the same time, there's also plenty of outdated data, from debunked scientific and medical theories to racist narratives. 'When you're dealing with such a large data set, there are some tricky issues around harmful content and language,' said Kristi Mukk, a coordinator at Harvard's Library Innovation Lab who said the initiative is trying to provide guidance about mitigating the risks of using the data, to 'help them make their own informed decisions and use AI responsibly.' ———— The Associated Press and OpenAI have a licensing and technology agreement that allows OpenAI access to part of AP's text archives. Matt O'brien, The Associated Press


Globe and Mail
3 hours ago
- Globe and Mail
Medtronic announces MiniMed as name for planned New Diabetes Company
GALWAY, Ireland, June 12, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the company's roots, reflecting its original name prior to its acquisition by Medtronic in 2001, and a deep 40-year history of being at the forefront of transforming diabetes care around the world.